Your Catalyst To a Lucrative Business
Tissue engineering has a broad spectrum of applications. It is used extensively in the repair & reconstruction of organs & cells whose functional capacities have decreased due to congenital anomalies, age, burns, and diabetic ulcers. Growing prevalence of degenerative disorders, such as Alzheimer’ s and Parkinson’ s favorably impacts demand for tissue regeneration. Due to a wide application scope in geology, biology, agriculture, and medical, DNA sequencing could expand robustly over the forecast period.
On the basis of applications, the industry is categorized into bioindustrial, biopharmacy, bioagriculture, and bioservices. Biopharmaceuticals are sub divided into recombinant proteins, orphan drugs, advanced drugs, and monoclonal antibodies. The recombinant proteins segment is expected to dominate the global industry from 2016 to 2024. A host of vaccines being produced these days are made of biorecombinant proteins. Such a trend could drive the segment considerably. The bioservices industry may register a high rate of growth because of surging investments in clinical research by biotechnology & pharmaceutical companies. Other drivers of this industry are rising complexities of biotechnology processes, stringent regulatory norms, and cost cuts.
As per regions, the global biotechnology market is divided into Asia Pacific, North America, Europe, and Rest of the World. North America may continue dominating the overall industry in the coming decade. Regional drivers are high reimbursement rates of medical policies, quality healthcare infrastructure, and greater awareness among the masses. Asia Pacific may register the fastest growth among all regions because of factors, such as surging healthcare expenditure and increasing disposable incomes. Prominent companies in the global industry are Seattle Genetics, United Therapeutics, Vertex Pharmaceuticals, Novo Nordisk, and BioMarin Pharmaceutical.
Recently, scientists from the University of Bath, U. K. began a 5 year project to save vegetables, such as kale, broccoli, and cabbage, commonly known as‘ Brassica vegetables’. Unpredictable weather conditions in the U. K. have been harming the yearly harvests of brassica vegetables and oilseeds over the past couple of years. The BRAVO( Brassica, Rapeseed and Vegetable Optimization) project, financed by the BBSRC( Biotechnology and Biological Sciences Research Council) aims at promoting plant development and combating crop losses. The project follows the doctrines of Brassica genomics, genetics, modeling & phenotyping.
Browse Related Category Market Reports @ https:// www. hexaresearch. com / researchcategory / biotechnology-industry
Follow Us: